Adjusting for indirectly measured confounding using large-scale propensity score

Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes

(2021) Yasser Albogami et al.   DIABETES CARE

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension

(2020) George Hripcsak et al.   JAMA Internal Medicine

Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen

(2020) Rachel B. Weinstein et al.   DRUG SAFETY

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis

(2020) Yeesuk Kim et al.   Scientific Reports

Evaluation of disability in patients exposed to fluoroquinolones

(2020) Marsha A. Wilcox et al.   BMC Pharmacology & Toxicology

The Blessings of Multiple Causes

(2019) Yixin Wang et al.   JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis

(2019) Marc A Suchard et al.   LANCET

OUP accepted manuscript

(2018)   BIOMETRIKA

Evaluating large-scale propensity score performance through real-world and synthetic data experiments

(2018) Yuxi Tian et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data

(2018) Martijn J. Schuemie et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

(2018) Elaine Ku et al.   Journal of the American Heart Association

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study

(2018) Blánaid M Hicks et al.   BMJ-British Medical Journal

Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research network

(2017) Jon D. Duke et al.   EPILEPSIA

Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.

(2016) Miguel A. Hernán et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Terms of Major Cardiovascular Disease Outcomes in Elderly Patients

(2015) Shu-Chen Chien et al.   MEDICINE

Measurement bias and effect restoration in causal inference

(2014) M. Kuroki et al.   BIOMETRIKA

Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients

(2014) L P Hasvold et al.   JOURNAL OF HUMAN HYPERTENSION

Massive Parallelization of Serial Inference Algorithms for a Complex Generalized Linear Model

(2013) Marc A. Suchard et al.   ACM Transactions on Modeling and Computer Simulation

Empirical Performance of a New User Cohort Method: Lessons for Developing a Risk Identification and Analysis System

(2013) Patrick B. Ryan et al.   DRUG SAFETY

Bias attenuation results for nondifferentially mismeasured ordinal and coarsened confounders

(2012) E. L. Ogburn et al.   BIOMETRIKA

Effects of Adjusting for Instrumental Variables on Bias and Precision of Effect Estimates

(2011) Jessica A. Myers et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Invited Commentary: Understanding Bias Amplification

(2011) J. Pearl   AMERICAN JOURNAL OF EPIDEMIOLOGY

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors Versus β-Blockers as Second-Line Therapy for Hypertension

(2010) David J. Magid et al.  

Matching Methods for Causal Inference: A Review and a Look Forward

(2010) Elizabeth A. Stuart   STATISTICAL SCIENCE

Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research

(2009) Peter C. Austin   COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

Should observational studies be designed to allow lack of balance in covariate distributions across treatment groups?

(2009) Donald B. Rubin   STATISTICS IN MEDICINE

Remarks on the method of propensity score

(2009) Judea Pearl   STATISTICS IN MEDICINE

Propensity scores

(2009) Ian Shrier   STATISTICS IN MEDICINE

Propensity scores and M-structures

(2009) Arvid Sjölander   STATISTICS IN MEDICINE

Author's Reply

(2008) Donald B. Rubin   STATISTICS IN MEDICINE

Letter to the Editor

(2007) Ian Shrier   STATISTICS IN MEDICINE